Original article Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials
نویسندگان
چکیده
Cattedra di Ematologia, Università Cattolica S. Cuore, Rome; Dipartimento di Biotecnologie cellulari ed Ematologia, Università “La Sapienza”, Rome; Centro Dati GIMEMA Dipartimento di Biotecnologie cellulari ed Ematologia, Università “La Sapienza”, Rome; Dipartimento di Epidemiologia e Biostatistica Istituto Superiore di Sanità, Rome; U.O.A. di Ematologia, Ospedale SS: Antonio e Biagio, Alessandria; Ematologia, Ospedale Generale Regionale, Bolzano; Divisione di Ematologia, Ospedale Oncologico “A. Businco”, Cagliari; Divisione di Ematologia, Ospedale Regionale “A. Pugliese”, Catanzaro; Divisione di Ematologia, Policlinico di Careggi, Firenze; Dipartimento di Scienze Mediche, Oncologiche e Radiologiche, Sezione di Medicina Interna, Oncologia ed Ematologia, Modena; Sezione di Ematologia Clinica, Ospedale “S. Francesco”, Nuoro; Divisione di Ematologia, Ospedale “S. Carlo”, Potenza; Cattedra di Ematologia, Università di Tor Vergata, Rome, Italy
منابع مشابه
Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials.
BACKGROUND The aim of the study was to evaluate the outcome of acute myeloid leukaemia (AML) in patients with a previous malignancy (sAML) treated with chemo- and/or radiotherapy, enrolled in conventional trials. PATIENTS AND METHODS In a multicentre setting, a prospective non-concurrent analysis was performed on 2513 new AML patients, aged 12-78 years, consecutively enrolled in EORTC-GIMEMA ...
متن کاملExpression Profiling of Microarray Gene Signatures in Acute and Chronic Myeloid Leukaemia in Human Bone Marrow
Background Classification of cancer subtypes by means of microarray signatures is becoming increasingly difficult to ignore as a potential to transform pathological diagnosis nonetheless, measurement of Indicator genes in routine practice appears to be arduous. In a preceding published study, we utilized real-time PCR measurement of Indicator genes in acute lymphoid leukaemia (ALL) and acute m...
متن کاملDetection of abl/bcr Fusion Gene in Patients Affected by Chronic Myeloid Leukaemia by Dual-Colour Interphase Fluorescence in situ Hybridisation
Conventional cytogenetic is the standard technique for detection of Philadelphia (Ph) chromosome in chronic myeloid leukemia (CML). Evaluation of abelson murine leukemia/breakpoint cluster region (abl/bcr) fusion using dual-colour fluorescence in situ hybridization (D-FISH) is an alternative approach allowing rapid and reliable detection of the disease. We employed the technique of interphase D...
متن کاملThe incidence of secondary leukemias.
BACKGROUND AND OBJECTIVE The term secondary leukemia is usually employed to indicate both forms of acute myeloid leukemia (AML) evolving from previous myelodysplasia and forms of acute leukemia developing after exposure to environmental or therapeutic toxins or radiation (therapy related). Secondary leukemias account for 10-30% of all AML. The majority of secondary leukemias resulting from the ...
متن کاملThe Effect of Monophosphoryl Lipid A on Maturation of DCs from Patients with Acute Myeloid Leukaemia
Background: Generation of monocyte-derived dendritic cells (MDDC) is induced in the presence of GM-CSF and IL-4, and a maturation stimulus is added to the monocyte culture to obtain mature Dendritic Cells (DCs) suitable for therapy. TNF-α is the most common cytokine used for activating DCs and generating mature MDDC either alone or in combination with other cytokines. Objective: To compare effe...
متن کامل